drugset / Trial / NCT00482612
Study of the Safety and Effectiveness of Esmirtazapine in Participants With Chronic Primary Insomnia (P05706)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine if esmirtazapine (Org 50081) is a safe and effective treatment for insomnia. It was anticipated that esmirtazapine would increase mean Total Sleep Time (TST) as recorded in sleep diaries relative to placebo.
Timeline
- Start
- 2006-12-07
- Primary completion
- 2008-08-11
- Completion
- 2008-08-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esmirtazapine | Small molecule | 1.5 mg | Oral |
| Subject | Esmirtazapine | Small molecule | 3 mg | Oral |
| Subject | Esmirtazapine | Small molecule | 4.5 mg | Oral |